Clinical trial

Effect of L-Arginine and Pycnogenol on Light to Moderate Hypertension and Endothelial Function

NCT02392767

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-10-01

PhaseNA

Study timeline

Study start (unknown)2014-10-01Date precision: month

Registry last updated2016-05-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Endothelial Dysfunctionunresolved

Hyperhomocysteinemiaunresolved

Hypertension Grade I, Subgroup "Borderline" (WHO)unresolved

Interventions

VerumDIETARY_SUPPLEMENT

PlaceboDIETARY_SUPPLEMENT

Sponsors & collaborators

Dr. Loges & Co. GmbHlead sponsor

BioTeSys GmbHcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02392767 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.